Sanofi Acquiring Synthorx for $2.5B to Strengthen Immuno-Oncology Portfolio

Coinspeaker Sanofi Acquiring Synthorx for $2. 5B to Strengthen Immuno-Oncology PortfolioSanofi announced that it had agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2. дальше »